首页|β-谷甾醇改善绝经后骨质疏松的实验研究

β-谷甾醇改善绝经后骨质疏松的实验研究

扫码查看
[目的]探究杜仲有效单体成分β-谷甾醇对小鼠绝经后骨质疏松的疗效及其潜在作用机制.[方法]将24只12周龄雌性C57BL/6J小鼠随机分为假手术组、模型组及β-谷甾醇干预组,每组8只,采用双侧卵巢切除术建立绝经后骨质疏松模型,术后假手术组及模型组给予0.9%氯化钠溶液灌胃,β-谷甾醇干预组给予β-谷甾醇灌胃,术后8周将各组小鼠处死取材,借助显微计算机断层扫描(micro-computed tomography,Micro-CT)观察β-谷甾醇干预对绝经后骨量丢失及骨小梁破坏的保护作用,并采用苏木素-伊红(hematoxylin-eosin,HE)染色对小鼠股骨远端区域进行组织形态学分析,同时通过抗酒石酸酸性磷酸酶(tartrate-resistant acid phosphatase,TRAP)染色及碱性磷酸酶(alkaline phosphatase,ALP)染色评估小鼠骨吸收与骨形成情况,并通过免疫组化检测各组样本的β-catenin表达水平.[结果]Micro-CT扫描结果显示,β-谷甾醇干预可减少绝经后骨量丢失及骨微结构破坏,HE染色证实β-谷甾醇可有效维持骨小梁数目及组织形态,并在一定程度上抑制雌激素缺乏引起的异常脂肪堆积现象.TRAP染色结果表明,β-谷甾醇并不影响破骨细胞形成,而免疫组化结果表明β-谷甾醇可显著促进成骨标志物ALP的表达.与此同时,β-谷甾醇可增加β-catenin在股骨远端区域的表达,提示β-谷甾醇促进骨形成,可能与其上调β-catenin信号通路有关.[结论]β谷甾醇体内干预可上调β-catenin信号通路,增强成骨分化,促进机体骨形成,从而改善绝经后骨质疏松.
Study on the Intervention Effect of β-sitosterol in the Postmenopausal Osteoporosis
[Objective]To explore the intervention effect of β-sitosterol,an effective monomer component of Eucommia ulmoides,on postmenopausal osteoporosis in mice and its potential mechanism.[Methods]Twenty-four female C57BL/6J mice of 12 weeks old were randomly divided into sham operation group,model group and β-sitosterol intervention group,with 8 mice in each group.The model of postmenopausal osteoporosis was established by bilateral ovariectomy.Mice in sham group and model group were given 0.9%sodium chloride solution and β-sitosterol intervention group was given β-sitosterol.Eight weeks after operation,all the mice were sacrificed and samples were collected.Micro-computed tomography(Micro-CT)was used to observe the protective effect of the β-sitosterol intervention on postmenopausal bone loss and trabecular bone breakage.Hematoxylin-eosin(HE)staining was used to analyze the bone histomorphology of the distal femur.The tartrate-resistant acid phosphatase(TRAP)staining and the alkaline phosphatase(ALP)staining were used to evaluate bone resorption and bone formation respectively.Then the expression level of β-catenin in each group was detected by immunohistochemistry.[Results]Micro-CT scanning showed that β-sitosterol could reduce bone loss and bone microstructure destruction in postmenopausal mice.HE staining also confirmed that β-sitosterol could effectively maintain the number and morphology of trabecular bone and inhibit abnormal fat accumulation caused by estrogen deficiency.TRAP staining also showed that β-sitosterol treatment did not affect osteoclast formation,while immunohistochemical results showed that β-sitosterol could significantly promote the expression of osteogenic marker ALP.Moreover,β-sitosterol can increase the expression of β-catenin in the distal femur to promote bone formation.[Conclusion]β-sitosterol treatment could enhance osteogenic differentiation and promote bone formation to relieve postmenopausal osteoporosis by upregulating β-catenin expression in vivo.

postmenopausal osteoporosisβ-sitosterolEucommia ulmoidesbone formationosteoblastβ-catenin

姜耘宙、汪正明、王瑞、项思成、金钊锴、童培建、吕帅洁

展开 >

浙江中医药大学附属金华中医院 浙江,金华 321017

上海中医药大学附属曙光医院

浙江中医药大学

浙江中医药大学附属第一医院(浙江省中医院)

展开 >

绝经后骨质疏松症 β-谷甾醇 杜仲 骨形成 成骨细胞 β-catenin

2024年度浙江省中医药科技计划(中医药临床研究计划项目)

2024ZL044

2024

浙江中医药大学学报
浙江中医药大学

浙江中医药大学学报

CSTPCD
影响因子:1.049
ISSN:1005-5509
年,卷(期):2024.48(2)
  • 15